Romano Brothers & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-358
Closed -$8.47K – 903
2022
Q4
$8.47K Buy
+358
New +$9.65K ﹤0.01% 754

Other funds holding TDOC

Romano Brothers & Co's TDOC Position: Q1 2023 in Review

Romano Brothers & Co sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 358 shares — an estimated $8.47K sold.

Romano Brothers & Co first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $8.47K in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Romano Brothers & Co reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Romano Brothers & Co sold 358 Teladoc Health shares in Q1 2023, an estimated $8.47K.
  • Romano Brothers & Co first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
  • Romano Brothers & Co's Teladoc Health position peaked at $8.47K in Q4 2022.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.